Literature DB >> 25588373

Opioid and chemokine receptor crosstalk: a promising target for pain therapy?

Stéphane Mélik Parsadaniantz, Cyril Rivat1, William Rostène2, Annabelle Réaux-Le Goazigo2.   

Abstract

Chemokines and opioids are important regulators of immune, inflammatory and neuronal responses in peripheral and central pain pathways. Recent studies have provided insights into the functional interactions between chemokine receptors and opioid receptors, and their role in pain modulation. In this Progress article, we discuss how crosstalk between these two systems might provide a molecular and cellular framework for the development of novel analgesic therapies for the management of acute and/or chronic pain.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25588373     DOI： 10.1038/nrn3858

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN： 1471-003X            Impact factor:   34.870


  51 in total

1.  Spinal CX3CL1/CX3CR1 May Not Directly Participate in the Development of Morphine Tolerance in Rats.

Authors:  Yawen Peng; Genhua Guo; Bin Shu; Daiqiang Liu; Peng Su; Xuming Zhang; Feng Gao
Journal:  Neurochem Res       Date:  2017-08-03       Impact factor: 3.996

Review 2.  Opioid-induced central immune signaling: implications for opioid analgesia.

Authors:  Peter M Grace; Steven F Maier; Linda R Watkins
Journal:  Headache       Date:  2015-03-31       Impact factor: 5.887

Review 3.  Pain in ankylosing spondylitis: a neuro-immune collaboration.

Authors:  Katayoon Bidad; Eric Gracey; Kasey S Hemington; Josiane C S Mapplebeck; Karen D Davis; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

4.  The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes.

Authors:  Alexander O Tarakanov; Kjell Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2015-07-02       Impact factor: 3.575

5.  Morphine counteracts the antiviral effect of antiretroviral drugs and causes upregulation of p62/SQSTM1 and histone-modifying enzymes in HIV-infected astrocytes.

Authors:  Myosotys Rodriguez; Jessica Lapierre; Chet Raj Ojha; Shashank Pawitwar; Mohan Kumar Muthu Karuppan; Fatah Kashanchi; Nazira El-Hage
Journal:  J Neurovirol       Date:  2019-02-11       Impact factor: 2.643

Review 6.  The Multifunctional Role of the Chemokine System in Arthritogenic Processes.

Authors:  Giovanni Bernardini; Giorgia Benigni; Rossana Scrivo; Guido Valesini; Angela Santoni
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

Review 7.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

8.  Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Authors:  Liting Deng; Wan-Hung Lee; Zhili Xu; Alexandros Makriyannis; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2016-10-20       Impact factor: 7.658

9.  Chronic postsurgical pain: is there a possible genetic link?

Authors:  Sabu Kumar James
Journal:  Br J Pain       Date:  2017-07-28

10.  Altered expression of glial markers, chemokines, and opioid receptors in the spinal cord of type 2 diabetic monkeys.

Authors:  Norikazu Kiguchi; Huiping Ding; Christopher M Peters; Nancy D Kock; Shiroh Kishioka; J Mark Cline; Janice D Wagner; Mei-Chuan Ko
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-14       Impact factor: 5.187
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.